Irreversible Inhibitors

Overview

Irreversible inhibitors are molecules that bind permanently to Enzymes, forming stable covalent bonds that inactivate the enzyme's catalytic activity. Unlike reversible inhibitors that can dissociate from their target, irreversible inhibitors cause lasting modifications to the enzyme structure, requiring the cell to synthesize new enzyme molecules to restore function. Research published in this journal examines the computational approaches used in designing drugs that act as irreversible inhibitors, focusing on how computer-aided methods facilitate the identification and optimization of compounds that form covalent bonds with specific enzyme targets. This work addresses the application of computational tools in predicting binding interactions, molecular docking, and structure-activity relationships that are essential for developing effective irreversible inhibitors as therapeutic agents. The topic holds significance in pharmaceutical development because irreversible inhibitors can provide prolonged therapeutic effects with less frequent dosing, and their mechanism-based design allows for highly selective targeting of disease-related Enzymes. Understanding the computational strategies for designing these compounds advances the rational development of medications for conditions where permanent enzyme inactivation offers clinical advantages, including certain cancers and infectious diseases where sustained inhibition of key enzymatic pathways is therapeutically beneficial.

Research published in this journal

1 peer-reviewed article, ranked by relevance. Each links to its DOI.

This page summarises published research for orientation; it is not medical or professional advice.

Related topics